We are live on ! Find out more
LRND icon

New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF
LRND

1 hedge funds and large institutions have $3.65M invested in New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF in 2022 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,820% more capital invested

Capital invested by funds: $190K → $3.65M (+$3.46M)

0% more funds holding

Funds holding: 1 → 1 (0)

0% more ownership

Funds ownership: 95% → 95% (0%)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

LRND Hedge Fund Activity: Q3 2022 in Review

1 of the 5,829 institutional investors tracked by Wall St. Rank reported a position in New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF (LRND) for Q3 2022, worth a combined $3.65M — up 1,820% from $190K a quarter earlier.

Fund positioning in LRND was balanced in Q3 2022: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF (LRND) as of Q3 2022, unchanged from Q2 2022.
  • Funds reported $3.65M of New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF stock for Q3 2022, up 1,820% quarter-over-quarter.
  • 0 funds opened new New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF positions in Q3 2022 and 0 closed out.

Based on aggregated 13F filings for Q3 2022.